WallStSmart
SLGL

Sol Gel Technologies Ltd

NASDAQ: SLGL · HEALTHCARE · BIOTECHNOLOGY

$74.04
+3.70% today

Updated 2026-04-30

Market cap
$230.14M
P/E ratio
P/S ratio
11.87x
EPS (TTM)
$-2.19
Dividend yield
52W range
$4 – $98
Volume
0.0M

Sol Gel Technologies Ltd (SLGL) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201420152016201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$174000.00$129000.00$22.90M$8.77M$31.27M$3.88M$1.55M$11.54M$19.39M
Revenue growth (YoY)-25.9%+17655.0%-61.7%+256.5%-87.6%-60.0%+642.5%+68.0%
Cost of revenue$0.00$300000.00$359000.00$300000.00$28.15M$40.58M$27.91M$20.38M$12.68M$342000.00$233000.00$109000.00
Gross profit$0.00$-300000.00$-359000.00$-126000.00$-28.02M$-17.67M$8.77M$10.89M$-8.80M$-21.99M$11.30M$19.28M
Gross margin-72.4%-21718.6%-77.2%100.0%34.8%-226.6%-1414.9%98.0%99.4%
R&D$2.93M$7.18M$17.02M$25.80M$28.15M$40.58M$27.91M$20.38M$12.68M$23.54M$17.80M$22.70M
SG&A$1.88M$2.46M$3.73M$6.00M$5.50M$8.28M$11.09M$8.45M$7.45M$7.37M$5.75M$4.18M
Operating income$-4.81M$-9.65M$-20.76M$-31.63M$-33.52M$25.95M$-30.23M$2.96M$-16.24M$-29.30M$-12.01M$-7.59M
Operating margin-18179.9%-25985.3%113.3%-344.7%9.5%-418.3%-1885.8%-104.1%-39.2%
EBITDA$-4.58M$-9.35M$-20.40M$-31.16M$-32.76M$-25.06M$-29.29M$3.84M$-15.68M$-28.96M$-10.35M$-7.48M
EBITDA margin-17909.2%-25394.6%-109.4%-333.9%12.3%-403.9%-1863.8%-89.7%-38.6%
EBIT$-4.81M$-9.65M$-20.76M$-31.46M$-33.52M$-25.95M$-30.23M$2.96M$-16.24M$-29.30M$-10.58M$-7.59M
Interest expense$0.00$0.00$0.00$0.00$0.00$1.37M$0.00$880000.00$1.32M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.85M$-9.66M$-20.77M$-31.57M$-32.20M$-24.61M$-27.40M$3.22M$-14.92M$-27.24M$-10.58M$-6.13M
Net income growth (YoY)-99.3%-115.0%-52.0%-2.0%+23.6%-11.3%+111.8%-563.3%-82.5%+61.2%+42.1%
Profit margin-18142.5%-24963.6%-107.4%-312.4%10.3%-384.3%-1752.8%-91.7%-31.6%